Liver resection versus transarterial chemoembolization for the treatment of intermediate‐stage hepatocellular carcinoma

BACKGROUND: The role of transarterial chemoembolization (TACE) as the standard treatment for intermediate‐stage hepatocellular carcinoma (HCC) is being challenged by increasing studies supporting liver resection (LR); but evidence of survival benefits of LR is lacking. We aimed to compare the overal...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Med
Autors principals: Chen, Shuling, Jin, Huilin, Dai, Zihao, Wei, Mengchao, Xiao, Han, Su, Tianhong, Li, Bin, Liu, Xin, Wang, Yu, Li, Jiaping, Shen, Shunli, Zhou, Qi, Peng, Baogang, Peng, Zhenwei, Peng, Sui
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2019
Matèries:
Clinical Cancer Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6488138/
https://ncbi.nlm.nih.gov/pubmed/30864247
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2038
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars